Key Insights

Highlights

Success Rate

71% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

18.2%

2 terminated out of 11 trials

Success Rate

71.4%

-15.1% vs benchmark

Late-Stage Pipeline

18%

2 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed with results

Key Signals

71% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 4 (2)

Trial Status

Completed5
Unknown4
Terminated2

Trial Success Rate

71.4%

Benchmark: 86.5%

Based on 5 completed trials

Clinical Trials (11)

Research Network

Activity Timeline